Health One in Ten Americans Now Takes GLP-1 Drugs for Weight Loss as Obesity Rate Drops July 8, 2026 GLP-1 Medication Use Surges Among American Adults The percentage of U.S. adults who currently take GLP-1 medications for weight loss purposes has risen to 11% in 2026, up significantly from…
Health CVS Health Restores Zepbound Coverage After Landmark Pricing Deal May 28, 2026 Major Shift in Weight-Loss Drug Coverage CVS Health announced Thursday it will restore coverage for Eli Lilly’s weight-loss drug Zepbound on select formularies. The pharmacy giant will add the treatment…
Health Daily Weight Loss Pill Shows Promise After Stopping Fat Jabs May 18, 2026 New Oral Treatment Offers Hope for Weight Maintenance A daily tablet designed to help people maintain weight loss after stopping obesity injections has shown promising results. The medication, called orforglipron,…